Estrogen Patch Shortage 2026: When Will It End, and What to Do Now

You have the prescription. You have had it for two years. And the pharmacist tells you what she told you last month, which is that she cannot get them, she does not know when she will, and she cannot tell you which pharmacy can.

That is not a paperwork problem. Estradiol patches have been hard to fill across the country since January 2026, when the American Society of Health-System Pharmacists (ASHP) first listed them as short, and they still are. Med Matrix is an HRT clinic offering hormone replacement therapy for Maine women, and this has become one of the most common calls we take.

Where the Estrogen Patch Shortage Stands Now

As of September 28, 2026, estradiol patches are still short in the United States, and no one has published a date for when that ends. The American Society of Health-System Pharmacists has listed estradiol transdermal systems in shortage since January 2026, and CBS News reported on September 3 that more than a dozen estradiol patch products were still on that list. The same day, the FDA acknowledged that patients are having trouble getting their usual patches because of increased demand, and said it is working with all six manufacturers to raise supply. It still has not added estradiol patches to its drug shortage database, which carried no estradiol product of any kind when we checked it on September 28.

So the practical answer is the frustrating one. Plan as though this continues, and build refill lead time into your routine instead of waiting on an announcement.

When Will the Estradiol Patch Shortage End?

No end date has been announced. The FDA's September 3, 2026 update gives no timeline, and the most specific public forecast we have found dates from May, when a Mayo Clinic menopause specialist told NBC News she expected things to be better by the end of the year. Anyone giving you a firm date is guessing.

What the FDA does say is worth knowing. It says manufacturers are adding shifts, increasing batch sizes, and adding equipment and production lines, and that the supply of FDA-approved estradiol patches has nearly doubled over the past year. It also says some of those steps can add supply in the near term, while larger manufacturing expansions may take more time because patches need specialized equipment and processes.

Read those two facts together. By the FDA's own count supply nearly doubled, and women still can't fill their prescriptions. That's how far demand jumped.

Even that forecast came with a hedge. The specialist was Dr. Stephanie Faubion, director of the Mayo Clinic's Center for Women's Health, and she added that no one knows exactly when the shortage will be over. The same NBC News piece reported that some patches could stay in shortage for years.

Signs that it's actually easing, for you:

• Your pharmacist can order your exact strength again, not a substitute.
• The ASHP shortage entry for estradiol transdermal systems, which is public and lists affected products by manufacturer and strength, starts showing your product as available.
• An FDA announcement. Given that the agency never formally listed the shortage, don't wait on this one.

Why the Patches Ran Out

Demand changed faster than supply could follow.

On November 10, 2025, the FDA and the Department of Health and Human Services announced they would remove the boxed warning from menopausal hormone therapy products, saying the old framing overstated the risk for many women. We wrote about that decision when it happened, and you can read the background in our piece on the boxed warning removal.

The effect was immediate. Women who had spent years being told hormone therapy was too dangerous to consider started asking about it again. Clinicians who had quietly stopped offering it started offering it again. And a large share of those new prescriptions were written for patches rather than pills, because transdermal delivery is often the preferred starting point.

Manufacturing did not move at the same speed. The FDA's own September update says demand rose following that November labeling action. By early 2026 ASHP had estradiol transdermal systems on its drug shortage list, and they are still on it.

The Confusing Part: The FDA Still Has Not Called It a Shortage

This is the detail that makes women feel like they are imagining things.

ASHP, the pharmacy body that most hospitals and pharmacists actually rely on, has listed estradiol patches as being in shortage since January. The FDA's September 3 update acknowledged that patients are struggling to get their usual patches, then said that although availability of certain products or brands may vary by pharmacy or location, estradiol patches remain available. So a woman can read a federal statement saying patches are available while standing in front of a pharmacy counter that has none.

Lawmakers have noticed the gap. On August 6, 2026, Rep. Debbie Dingell and seven House colleagues wrote to the FDA about the shortage and asked, among other things, for a timeline to resolve it. CBS News reported in September that House members had urged the agency to add estradiol patches to its federal drug shortage database, and that physicians were asking for the same thing. National coverage has tracked this for months. CNBC reported in June 2026 that estrogen patches were hard to find as more women sought menopause treatment, and PBS NewsHour and local ABC stations have run the same story since.

The designation matters more than it sounds like it should. An official listing changes what manufacturers, pharmacies, and insurers are able to do about a supply gap. Without one, the problem stays a private frustration between you and whoever answers the phone at your pharmacy.

Are Estradiol Gels, Pills, and Other Estrogen Products Short Too?

The patches are the product in trouble. The FDA's September statement covers patches only, and when we checked the FDA drug shortage database on September 28, it listed no estradiol product in any form, and no conjugated estrogen such as Premarin.

That is less reassuring than it sounds. The same database has never listed the patches either, so an empty entry only tells you the FDA hasn't declared a problem. Whether your pharmacy has the product on its shelf is a separate question.

Two things worth knowing. CBS News reported that demand for progesterone pills, which are often prescribed alongside estrogen, has also grown, leading to uneven supply. And before your prescriber writes you a replacement, ask the pharmacy to confirm it is actually in stock, so you are not starting the same search over with a new prescription.

What Not to Do While You Wait

Most of the harm we see from a supply gap does not come from the gap. It comes from what people do about it on their own.

Do not cut or divide your patches. It is the first thing everyone thinks of and it is the wrong move. Patches are designed and tested to release medication at a set rate across an intact surface. Cutting one changes the delivery in ways the manufacturer has not tested and your prescriber has not accounted for. If stretching your supply is genuinely the only option left, that is a decision your prescriber makes, not one you make with scissors.

Do not stretch the wear time. Leaving a twice-weekly patch on for five days does not give you five days of medication. It gives you two days of medication and three days of declining levels, which is usually when symptoms come back hardest.

Stopping cold to wait it out is its own mistake. An abrupt stop is a real change to your body, and it is worth a phone call before it happens rather than after. The FDA's advice says the same: do not stop or change your medication without talking with your healthcare provider.

Any website that will ship hormones without a prescription. Walk away. A seller willing to do that is telling you something important about how it operates. You have no way to confirm what is in the package, what dose it actually delivers, or where it came from.

What to Do This Week

Start before you are on your last patch. Two weeks of lead time gives your prescriber options. Two days does not.

Call your prescriber first, not the pharmacy. The pharmacy can only tell you what they do not have. Your prescriber is the one who can change what is written.

Ask your pharmacist to check across manufacturers and strengths. The shortage has never been uniform. Different manufacturers, different dose strengths, and different patch sizes have come in and out of supply at different times all year. A dose that is unavailable from one maker is sometimes sitting on a shelf under a different label. The FDA points patients here too: your pharmacist may be able to find another FDA-approved estradiol patch that can be substituted for yours, when that is appropriate.

Ask about the other schedule. Patches come in two types, one changed twice a week and one changed once a week. Dr. Faubion told NBC News that moving between the two can help women stay on a patch when their usual brand and dose is short. That switch changes what is on your prescription, so it is your prescriber's call.

Widen the radius, and call independents. Chain inventory systems often only show you the chain. Independent pharmacies in southern Maine are worth calling directly, and they will usually tell you honestly what they can order.

Watch what a partial fill costs you. A physician told CBS News that some patients who normally get a 90-day supply on one copay are being handed 30-day supplies instead, and paying the copay each time. If that is happening to you, ask your insurer how it handles partial fills during a shortage. If cost is part of the switch decision, our breakdown of hormone therapy without insurance covers what the options run.

Ask what else is reasonable for you specifically. Estrogen also comes as creams and gels, as pills, and as vaginal rings, and some women ask about hormone pellets. Which of those makes sense depends on your history, your symptoms, and why you were put on a patch in the first place. You can't look that up in a table. It takes a conversation with someone who knows your chart.

If You Switch, Your Levels Are Worth Rechecking

This is the part that gets skipped, and it is the part that determines whether the switch actually works.

Two products that both deliver estradiol do not necessarily deliver it the same way. Absorption differs between routes, between products, and between people. A dose that reads as equivalent on paper can land differently in your bloodstream, and the way you find that out is by measuring rather than by waiting to see how you feel in three months.

If you have had to change products this year, a follow-up conversation and a look at where your levels actually sit is reasonable. Our advanced testing work exists for exactly this kind of question, and the markers involved are the same ones we walk through in blood tests before starting HRT. It is also why our hormone replacement therapy patients are monitored on an ongoing basis rather than handed a prescription and sent away.

What This Looks Like at Med Matrix

Women come to us having already done the hard part, which is figuring out that something is wrong and refusing to be told it is nothing. The most common thing we hear is some version of what one patient put plainly: her doctor looked at her and said there was no point in checking her hormones.

We check. Our hormone balance work treats what the results and your symptoms actually show, and we keep checking, because hormone therapy is not a one-time decision. When a supply problem like this one hits, and the night sweats start wrecking your sleep again, that ongoing relationship is the difference between a two-week disruption and six months of feeling like yourself slipping away again.

Our women's health team works with patients across southern Maine, and we hold a 4.8 star rating across 190+ Google reviews.

Common Questions

Is the estrogen patch shortage over?

No. As of September 28, 2026, estradiol patches are still hard to fill in many places, ASHP still lists them in shortage, and the FDA's September 3 update says the agency is still working with manufacturers so that supply keeps pace with demand.

Is there officially an estrogen patch shortage?

It depends which official you ask, which is the heart of the problem. ASHP has listed estradiol transdermal systems in shortage since January 2026. The FDA acknowledged on September 3, 2026 that patients are having difficulty getting their usual patches, but it still says the patches remain available and has not added them to its drug shortage database. House lawmakers and physicians have pressed the agency to change that.

When will estradiol patches be available again?

No one has given a reliable date. The FDA says some of the steps manufacturers are taking can add supply in the near term, while larger manufacturing expansions may take more time. Availability also varies by brand, strength, and pharmacy, so a patch that is gone at one counter may be in stock at another today. Plan for the shortage to continue, and keep two weeks of lead time on every refill.

Can I cut my estradiol patch in half to make it last longer?

Not on your own. Patches release medication across an intact surface at a tested rate, and cutting one changes that in ways nobody has measured for you. If rationing your supply is genuinely the last option, your prescriber should be the one making that call.

Are estradiol gels and pills in short supply too?

The FDA drug shortage database listed no estradiol gel, pill, or injection when we checked on September 28, 2026, and national reporting has centered on patches. That database never listed the patches either, though, so ask the pharmacy to confirm a replacement is in stock before your prescriber switches you.

Can I just switch to a pill instead?

Sometimes, and sometimes not. Oral and transdermal estrogen are processed by the body differently, and there are reasons a patch may have been chosen for you specifically. That makes it a real clinical decision for your prescriber, and one worth making with your history in front of them.

What if I have to go without for a week?

Tell your prescriber that it is about to happen instead of afterward. Symptoms like hot flashes and night sweats usually return as levels fall, and how much that matters depends on your dose, how long you have been on it, and why you are taking it. A gap you have planned for is a very different thing from one you discover on a Sunday.

You Should Not Have to Manage This Alone

A supply problem you did not cause should not cost you a year of feeling well. If you are rationing patches, calling pharmacies on your lunch break, or wondering whether the levels you fought to get right are still right, that is worth a real conversation with someone who will look at the actual numbers.

Start feeling like yourself again. Book your free discovery call and we will look at where you are, what your labs say, and what a workable plan looks like while this shortage lasts.